Revitope
Powered for Precision: Revolutionizing immunotherapy to safely and effectively treat more cancers
6 employees · est. 2016 · Cambridge, United States
Surface Oncology Inc.
#lifeunderthesurface #BBJBestPlacesToWork2023,2022,2021 #BostonGlobeTopPlacesToWork2023,2022,2021
14 employees · est. 2014 · Cambridge, United States
Surface Oncology Inc. is the older company (2016 vs 2014); Surface Oncology Inc. is the larger of the two.
Side-by-Side Comparison
| Metric | Revitope | Surface Oncology Inc. |
|---|---|---|
| Founded | ||
| Founded | 2016 | 2014 older |
| Headquarters | ||
| Headquarters | Cambridge, United States | Cambridge, United States |
| Employees | ||
| Employees | 6 | 14 larger |
| Industry | ||
| Industry | Biotechnology, Health Care, Health and Wellness | Biotechnology, Health Care, Life Sciences |
| Funding Stage | ||
| Funding Stage | Series Unknown | Post Ipo Equity |
| Total Funding | ||
| Total Funding | $8.50M | $88.90M |
| Funding Rounds | ||
| Funding Rounds | 1 | 4 |
| Services | ||
| Services | Not tracked yet | Not tracked yet |
| Target Customers | ||
| Target Customers | Not tracked yet | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Immunotherapy, Cancer Treatment, T Cell Redirecting Biologics, Precision Medicine, Immune-based Therapies, Programmable Antibody Circuits, Immunodominant Viral Peptide, Cancer Immunotherapy, Biologic Prodrugs, Antibody Technology, Oncology, Clinical Studies, Viral Immune Response, Antigenic Targeting | Immuno-oncology, Cancer Therapy, TME Biology, Immune System, Antibody Candidates, Cancer Research, Novel Immunotherapy Targets, Tumor Microenvironment, Immune Evasion, Biological Pathways, Clinical-stage, Cancer Treatments, Scientific Founders, Biological Research |
| Website | ||
| Website | revitope.com | surfaceoncology.com |
About Revitope
Revitope, an early stage biotechnology company, is focused on revolutionizing immunotherapy to effectively treat a wide range of cancers. The company's Programmable Antibody Circuits (PACs) aim to redirect T cells to the surface of cancer cells, activating a potent immune response while expanding an...
About Surface Oncology Inc.
Surface Oncology Inc. is a clinical-stage immuno-oncology company that was founded in 2014. The company is headquartered in the United States and has recently received a significant $28.90MPost-IPO Equity investment on 20 May 2020 from BVF Partners, EcoR1 Capital, Venrock Healthcare Capital Partners...
We will tell you when either one moves
BounceWatch watches Revitope and Surface Oncology Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Revitope and Surface Oncology Inc. — by email.
Frequently Asked Questions
Compare Revitope with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Revitope on 12 Sep 2024, and Surface Oncology Inc. on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.